Compound Detail
CHEMBL5180206
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5180206 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | XIJVSXOHZZEEAH-UHFFFAOYSA-N |
5
Targets
5
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
468.0
MW (Da)
4.09
ALogP
3
HBA
2
HBD
61.4
PSA (Ų)
0.58
QED
0
Ro5 Violations
9
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 5 meas. best 4.55
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| A549 | IC50 | = | 28020.0 | nM | 4.55 | Cytotoxicity against human A549 cells assessed as cell growth inhibition | 35809817 |
| MCF7 | IC50 | = | 35460.0 | nM | 4.45 | Cytotoxicity against human MCF7 cells assessed as cell growth inhibition | 35809817 |
| L02 | IC50 | = | 70390.0 | nM | 4.15 | Cytotoxicity against human L02 cells assessed as cell growth inhibition | 35809817 |
| HeLa | IC50 | = | 86210.0 | nM | 4.06 | Cytotoxicity against human HeLa cells assessed as cell growth inhibition | 35809817 |
| MGC-803 | IC50 | = | 89100.0 | nM | 4.05 | Cytotoxicity against human MGC-803 cells assessed as cell growth inhibition | 35809817 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35809817 | 10.1016/j.bmcl.2022.128880 | Adenosylhomocysteinase | 2 |
| 35809817 | 10.1016/j.bmcl.2022.128880 | MCF7 | 1 |
| 35809817 | 10.1016/j.bmcl.2022.128880 | A549 | 1 |
| 35809817 | 10.1016/j.bmcl.2022.128880 | HeLa | 1 |
| 35809817 | 10.1016/j.bmcl.2022.128880 | MGC-803 | 1 |
| 35809817 | 10.1016/j.bmcl.2022.128880 | L02 | 1 |
Data from ChEMBL 36 via Core Engine